This book provides a clear analysis of the multi-level impacts of the existing international law regime related to genetic resources on developing countries. It does so through a cogent exposition of the different areas of the law pertaining to genetic resources that are relevant and impact on people's rights and livelihoods. Its focus on equity is a welcome addition to the literature.' - Philippe Cullet, University of London, UK'Camena Guneratne's thought-provoking book critically evaluates the clash between the private property approach to genetic resources embedded in international intellectual property conventions, and the competing values embedded in a variety of other conventions and laws. She contests key assumptions behind intellectual property regimes supporting genetic commerce, distinguishing the genetic 'commons' from other types of resource. This book provides a comprehensive scholarly dealing with the topics noted in its title, but also should increase debate about policy failures in responding to the risks to the underprivileged of the instruments we use to pursue our economic interests of the majority.' - Paul Martin, University of New England, Australia 'This is a wonderful book. All to often in the quest to preserve biodiviersity, we forget that the equation of equity hs to be the forefront of the debates on sustainable development. Dr. Guneratne rectifies this mistake.This linkage between biodiversity, politics and international law is of such a high calibre, that it is likely that this work will become a key text for students and scholars alike.' - Alexander Gillespie, University of Waikato, New Zealand This book examines current developments in international law which regulate the uses of plant genetic resources for food and agriculture, and the various property regimes which are applied to these resources by these international agreements. In the current context of the global food crisis, the development and stability of national agricultural systems is an urgent concern, particularly among developing countries. This stability, and national food security, will potentially be threatened if these countries are unable to have free access to agricultural crop plants. This book analyses a range of international agreements including the recently adopted Nagoya Protocol and demonstrates that in their current implementation they favor private ownership of these resources rather than free access. The book takes the position that this is inherently inequitable and these resources should be maintained in the public domain. This book will be of use to a wide range of readers from students and scholars to those working in the fields of trade and intellectual property, human rights, environmental conservation and advocacy on international issues. It contains a rigorous legal analysis of current international law development on the issue based on the negotiations which have taken place in the relevant forums, and will therefore be particularly useful to lawyers and legal scholars. It is also written in an uncomplicated style which makes it readily accessible to non-lawyers and the case studies and empirical data used throughout the book adds to its interest.

Key Account Management Excellence in Pharma & Medtech is designed to help life sciences practitioners develop and execute innovative and effective key account management (KAM) strategies and capabilities. Pharmaceutical and medtech companies are increasingly pursuing KAM in response to the rapid rise of large, sophisticated and complex healthcare provider and payer systems and groups. Those that invest the time to get KAM right will protect their business and grow with these rising customers. This book is groundbreaking in both its scope and its tailoring of leading KAM practices specifically for life sciences. The central theme is that "key account management is an organization-wide business strategy, not just a role or a sales-specific initiative." KAM is a strategy focused on providing unique offerings and value through an orchestrated, cross-functional, go-to-market model designed specifically to address the needs and engagement preferences of a unique segment of customers. The insights and practices shared in this book are designed to be a valuable reference at every stage of the KAM journey. The book has been designed to facilitate a common language and deep understanding of KAM issues and leading practices organization-wide-particularly for life sciences leaders, account managers and cross-functional team members responsible for building, transforming and supporting their organization's KAM strategies and capabilities.

A biotech manager's handbook lays out - in a simple, straightforward manner - for the manager or would-be entrepreneur the basic principles of running a biotech company. Most managers in biotechnology companies are working in their first company or in their first managerial role. Their expertise and experience in the scientific part of the work can be taken as a given but there is a whole range of other skills to be learned and areas of expertise to come to terms with. Small companies do not have big budgets to hire people or time to become an expert in so many areas. The book starts by outlining the state of the biopharmaceutical industry and goes on to explain the importance of planning (no matter what the size of the company). Succeeding chapters deal with the basics of intellectual property, perspectives from a university technology transfer office and how to raise some initial funding from an investor and entrepreneur.
No other 'how to' manual exists for this sectorWritten by a range of expert professionals in each area, all in one bookIs the only 'bench to bedside' book covering the whole spectrum of development

This book analyses how China s firms in the consumer electronics (CE) sector have developed their business strategy and corporate governance during the reform process. The CE sector is one of China s most important and dynamic manufacturing sectors. As one of the earliest market-oriented sectors after 1978, its experience illustrates the adoption of the Western model of management in China. This is the first book to analyse the link between business strategy, corporate governance and performance of firms, explicitly comparing state-, collective-, and privately-owned firms. This book argues that the competitive dynamics of the market are central to the survival of firms in contemporary China.
Focuses on the state, collective and private Chinese firms in the consumer electronics sectorProvides insights into the interactions among political, economic and corporate factors in the China business environment that influence the strategies and performance of these firmsCompares the corporate governance of these Chinese firms across different ownership forms"

The emergence of platforms is a novel phenomenon impacting most industries, from products to services. Industry platforms such as Microsoft Windows or Google, embedded within industrial ecosystems, have redesigned our industrial landscapes, upset the balance of power between firms, fostered innovation and raised new questions on competition and innovation. Annabelle Gawer presents cutting-edge contributions from 24 top international scholars from 19 universities across Europe, the USA and Asia, from the disciplines of strategy, economics, innovation, organization studies and knowledge management. The novel insights assembled in this volume constitute a fundamental step towards an empirically based, nuanced understanding of the nature of platforms and the implications they hold for the evolution of industrial innovation. The book provides an overview of platforms and discusses governance, management, design and knowledge issues. With a multidisciplinary approach, this book will strongly appeal to academics and advanced students in management, innovation, strategy, economics and design. It will also prove an enlightening read for business managers in IT industries.

This is an original and very well structured and informative book. Its particular interest stems from the multidimensional and detailed analysis of a set of core technologies and their uneven diffusion process in eight countries of quite different levels of development. It challenges received ideas about what really matters to democratize the access to new technologies and provides evidence-based suggestions for policy design. Scholars and students interested in the technological side of inequality will read this book with delight.' - Judith Sutz, Universidad de la Republica, UruguayInequality is one of the main features of globalization. Do emerging technologies, as they spread around the world, contribute to more inequality or less? This unique interdisciplinary text examines the relationships between emerging technologies and social, economic and other forms of inequality. Susan Cozzens, Dhanaraj Thakur, and the other co-authors ask how the benefits and costs of emerging technologies are distributed amongst different countries - some rich and some poor. Examining the case studies of five technologies across eight countries in Africa, Europe and the Americas, the book finds that the distributional dynamics around a given technology are influenced by the way entrepreneurs and others package the technology, how governments promote it and the existing local skills and capacity to use it. These factors create social and economic boundaries where the technology stops diffusing between and within countries. The book presents a series of recommendations for policy-makers and private sector actors to move emerging technologies beyond these boundaries and improve their distributional outcomes. Offering a broad range of mature and relatively new emerging technologies from a diverse set of countries, the study will strongly appeal to policy-makers in science, technology and innovation policy. It will also benefit students and academics interested in innovation, science, technology and innovation policy, the economics of innovation, as well as the history and sociology of technology. Contributors: B. Beckert, I. Bortagaray, L. Brito, R. Brouwer, S. Cozzens, M.P.Falcao, S.D. Gatchair, J.A. Holbrook, L.A. Pace, D. Thakur

The U.S. computer software industry dominates the globe. But why has this critical industry succeeded so dramatically in world competition when so many other strategic technologies have fallen to foreign suppliers? In a detailed and well-reasoned economic analysis, Siwek and Furchtgott-Roth present the first truly comprehensive examination of international trade in computer software.

The authors identify software as one of the fastest-growing industries in the United States as measured by value-added to gross domestic product, employment, and foreign sales. They document the historical importance of U.S.-produced software in both American and foreign markets and they present country-by-country assessments of software markets around the world. Siwek and Furchtgott-Roth identify the principal areas of advantage held by the U.S. software industry and they go on to assess the future prospects of U.S. software in world markets.

A new era of space-based technology and interplanetary exploration will produce cost-effective solutions and innovative technologies to fulfill current societal needs. Space-Based Technologies and Commercialized Development: Economic Implications and Benefits introduces the concept of space-based technology commercialization and offers a first-time analysis of plausible opportunities. This essential reference examines the overall marketability of tourism in outer space, including business case studies on celestial solar power and space debris that demonstrate the potential of cosmic technologies in the context of interplanetary business.

This volume fills an important need for understanding about the interplay between China's intellectual property protection system and the potential for innovation in China's economy. Using examples from the pharmaceutical and biotech industries, the author suggests that, despite the widely documented challenges facing China's IPR protection system, the system has a demonstrable effect on innovation. The author suggests that China's patent system promotes innovation through economic incentives, soft factors of public encouragement, and intentional development strategies. This book is also useful as an overview of China's biotech and pharmaceutical sectors, offering a range of richly detailed case studies on China's industrial development strategies in these sectors. A number of important patent disputes between Chinese and foreign companies are also examined to useful effect. In the highly contentious policy world of intellectual property protection and pharmaceutical and biotech industry development, the volume offers a refreshing combination of detail and insight.'uPitman B. Potter, University of British Columbia, Canada'Yahong Li's pioneering study, Imitation to Innovation in China, breaks new ground in closely examining the extent to which the Chinese government's patent policies and patent activity by Chinese firms are influencing China's coming transformation from an imitation-oriented country to an innovation-oriented one. Her combination of theoretical and empirical approaches exploring the links between public policy, patenting activity and technological innovation (commercialization) is an important contribution to development studies, not just for China but for other newly innovative countries as well.'uWilliam O. Hennessey, Franklin Pierce Law Center, USA Following decades in which China's approach to technology has been to imitate, the country is now transforming itself to become innovation-oriented. This pioneering study examines whether patents play as similar a role in promoting innovation in China as they do in the West, exploring the interplay between patents and China's biotechnology and pharmaceutical industries in particular. The author argues for a stronger patent regime based on an extensive review of the technological capacity, R&D models, patent filings and litigations, and issues in patent law, which involve China's biotechnology and pharmaceutical industries. By comparing China with other developing countries and analyzing China's uniqueness in terms of its development stage, technological capacity and the strengths and weaknesses in its patent system, the author concludes that China is distinguished from the prevailing view that patents play a limited role in innovation in developing countries. The book also discusses whether and how patents can promote innovation in China's biotechnology and pharmaceutical industries, based on the study of market scale, R&D capacity, innovation model and patent legislation and cases.

Key Account Management Excellence in Pharma & Medtech is designed to help life sciences practitioners develop and execute innovative and effective key account management (KAM) strategies and capabilities. Pharmaceutical and medtech companies are increasingly pursuing KAM in response to the rapid rise of large, sophisticated and complex healthcare provider and payer systems and groups. Those that invest the time to get KAM right will protect their business and grow with these rising customers. This book is groundbreaking in both its scope and its tailoring of leading KAM practices specifically for life sciences. The central theme is that "key account management is an organization-wide business strategy, not just a role or a sales-specific initiative." KAM is a strategy focused on providing unique offerings and value through an orchestrated, cross-functional, go-to-market model designed specifically to address the needs and engagement preferences of a unique segment of customers. The insights and practices shared in this book are designed to be a valuable reference at every stage of the KAM journey. The book has been designed to facilitate a common language and deep understanding of KAM issues and leading practices organization-wide-particularly for life sciences leaders, account managers and cross-functional team members responsible for building, transforming and supporting their organization's KAM strategies and capabilities.

* Focus on seven critical, fast-paced industries where innovation capability is essential * Written by two prominent thought leaders with 50 years of combined experience working with hundreds of companies across industries * Provides templates to immediately put the book's frameworks in place to develop an organization's innovation plan

The Future of Work in Asia and Beyond presents the findings and associated implications arising from a collaborative research study conducted on the potential impact of the Fourth Industrial Revolution (4IR - or Industry 4.0) on the labour markets, occupations and associated future workforce competencies and skills across ten countries. The 4IR concerns the digital transformation in society and business - an interface between technologies in the physical, digital and biological disciplines. The book explores many related issues: the nature of the 4IR, as well as demographic, generational and socio-cultural issues, economic and political perspectives, public and private sector similarities and differences, business strategy and managerial implications, human resource management/planning strategies, policies and practices, industry innovations, 'best practice' cases and comparative country studies. Chapters are based on a framework which combines labour market and multiple stakeholder theories. Issues are explored through the perceptions of organisational managers based in Australia, China, India, Indonesia, Malaysia, Mauritius, Nepal, Singapore, Taiwan and Thailand to provide an analysis of organisational, industry and government preparedness for the 4IR. This book is recommended reading for anyone wanting to gain an understanding of the 4IR and a range of related challenges and issues, as well as suggested strategies for governments, education and industry that are necessary to address them.

In this book, Florence Wambugu and Daniel Kamanga of "Africa Harvest Biotech Foundation International" bring together expert African authorities to critique various biotechnology initiatives and project future developments in the field in Africa. For the first time, African voices from multidisciplinary fields as diverse as economics, agriculture, biotechnology, law, politics and academia, demand to be allowed to set the continent s biotech development agenda. This book argues that there is a great future for biotechnology in Africa which sidesteps western interests that do not match those of the local populace. In these diverse chapters, Africa s political and scientific leaders demand a greater say in how research and development funds are allocated and spent. They argue that Africa s political leaders must see both clear benefits and have elbow-room to drive the change required. This is the way that African governments can employ workable policies, suitable biosafety legislation and regulation and respond effectively to public-private partnerships. Wambugu and Kamanga show that biotechnology has the potential to improve food security and standard of living as well as mitigate the detrimental effects of climate change on the African continent."

This book is an everything-included approach to understanding drones, creating an organization around using unmanned aircraft, and outlining the process of safety to protect that program. It is the first-of-a-kind safety-focused text book for unmanned aircraft operations, providing the reader with a required understanding of hazard identification, risk analysis, mitigation, and promotion. It enables the reader to speak the same language as any civil aviation authority, and gives them the toolset to create a safety risk management program for unmanned aircraft. The main items in this book break down into three categories. The first approach is understanding how the drone landscape has evolved over the last 40 years. From understanding the military components of UAS to the standards and regulations evolution, the reader garners a keen understanding of where we came from and why it matters for moving forward. The second approach is in understanding how safety risk management in aviation can be applied to drones, and how that fits into the regulatory and legislative environment internationally. Lastly, a brief synopsis of the community landscape for unmanned aircraft is outlined with interviews from important leaders and stakeholders in the marketplace. Drones fills a gap in resources within the unmanned aircraft world. It provides a robust understanding of drones, while giving the tools necessary to apply for a certificate of authorization, enabling more advanced flight operations for any company, and developing safety risk management tools for students and career professionals. It will be a mainstay in all safety program courses and will be a required tool for any and all individuals looking to operate safely and successfully in the United States.

Large-scale, interoperable biobanks are an increasingly important asset in today's life science research and, as a result, multiple types of biobanks are being established around the globe with very different financial, organizational and legal set-ups. With interdisciplinary chapters written by lawyers, sociologists, doctors and biobank practitioners, Global Genes, Local Concerns identifies and discusses the most pressing issues in contemporary biobanking. This timely book addresses pressing questions such as: how do national biobanks best contribute to translational research?; What are the opportunities and challenges that current regulations present for translational use of biobanks?; How does inter-biobank coordination and collaboration occur on various levels?; and how could academic and industrial exploitation, ownership and IPR issues be addressed and facilitated? Identifying that biobanks foundational and operational set-ups should be legally and ethically sound, while at the same time reflecting the hopes and concerns of all the involved stakeholders, this book contributes to the continued development of international biobanking by highlighting and analysing the complexities in this important area of research. Academics in the fields of law and ethics, health law and biomedical law, as well as biobank managers and policymakers will find this insightful book a stimulating and engaging read. Contributors include: T. Bossow, T.A. Caulfield, B.J. Clark, A. Hellstadius, J.R. Herrmann, K. Hoyer, M. Jordan, J. Kaye, N.C.H. Kongsholm, K. Liddell, J. Liddicoat, M.J. Madison, T. Minssen, B. Murdoch, W. Nicholson Price II, E. Ortega-Paino, M. Prictor, M.B. Rasmussen, K. Sargsyan, J. Schovsbo, A.M. Tupasela, E. van Zimmeren, F. Vogl, H. Yu, P.K. Yu

Originally published in 1988, this book explores how new technologies, industrial innovation and the growth of high technology industry have affected regional employment and economic change in different European countries. It discusses the factors which make some areas better suited than others to the development of the new industries, emphasising how fuctional integration and dependence upon highly-qualified manpower tend to concentrate these industries in particular locations. Attempts to encourage innovation and the development of high technology industry in old industrial areas are discussed, with particular reference to the role of large firms, training programmes and government policies.

This book, originally published in 1988, reviews the development of high technology industries at global and selected national and local levels, providing a unique insight into reasons for and consequences of such modern industrial development. It appraises government policies for assisting the development of this sector and focuses on the fact that high tech industry tends to be concentrated in particular regions of countries which attain the status of 'successful populations'. High technology industry seems to offer little benefit to declining manufacturing areas and the book offers explanations for these regional concentrations and assesses the likely consequences.

The contemporary opioid crisis is widely seen as new and unprecedented. Not so. It is merely the latest in a long series of drug crises stretching back over a century. In White Market Drugs, David Herzberg explores these crises and the drugs that fueled them, from Bayer's Heroin to Purdue's OxyContin and all the drugs in between: barbiturate "goof balls," amphetamine "thrill pills," the "love drug" Quaalude, and more. As Herzberg argues, the vast majority of American experiences with drugs and addiction have taken place within what he calls "white markets," where the prescription of addictive drugs is legal and medically approved. These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its "drug wars"--until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America's divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets while caring for people with addiction by ensuring them safe, reliable access to medication-assisted treatment. Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century. By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself--ideas that have been failing us catastrophically for over a century.

Export marketing holds the promise of vastly increased sales and market share for companies of all sizes. This book gives you the tools you need to go from ground zero -- virtually no experience in international marketing -- to the point where you can confidently pull together an effective plan for marketing your products overseas.

This study of Ferranti in its last six years of a long history provides a detailed exposition of the British and American businessmen who combined to terminate one of the UK's leading defence electronics firms. Involving action in the Middle East, South Africa and Pakistan, as well as the UK and USA, this highlights the precarious nature of international arms trading.

The objective of a synchronized production system is to harmonize all the elements of the manufacturing process based on the Just-in-Time strategy. This strategy is designed to improve return on investment in business by reducing in-process inventory and its associated costs. The process is driven by a series of signals, or Kanban, that tell production processes to make the next part. The Synchronized Production System sets out the fundamentals of the process clearly and concisely and shows the remarkable results that can be achieved: Money previously tied up in stock is released Quicker response times to customer orders, leading to increased customer satisfaction Custom manufacture to order - improving equity return by reducing risk Dramatically improved product quality This ground-breaking book also explains how to improve performance through changes to management processes making it an invaluable reference for managers in all types and size of business.

The process of development in recent times has been characteristically marked by the expanding reach of multinational enterprises, flows of foreign direct investment, unprecedented growth of information and communication technologies (ICT) and knowledge-based industries, and infusion of ICT across the entire spectrum of industries and activities. High-tech knowledge-based industries like information technology, biotechnology, pharmaceuticals and so on have played an important role in the transition of Chinese and Indian economies-the two largest and fastest growing economies. This inter-disciplinary book offers an in-depth understanding of the behaviour of firms in these industries, analysing the strategies they adopt in a globally competitive environment, the role they have played in ushering in the growth revolution in China and India, and the contribution they have made to the nature and growth of employment. This study also dwells upon the emerging nature of scientific and technological developments like nanotechnology, novel materials, spintronics and quantum computers, with the conclusion that in the future, knowledge and technology are going to be the real sources of wealth for nations.

Bang & Olufsen, the famous Danish producer of high-end home electronics, is well known as an early exponent of value-based management: the idea that there should be consistency in what the organisation does, a certain continuity between what the company develops and sells, and the beliefs and practices of the employees. This study investigates how company values are communicated and the collective identity is articulated through the use of such concepts as 'culture', 'fundamental values', and 'corporate religion', as well as how employees negotiate these ideas in their daily working lives. As this book reveals, the identification of values, meant to create cohesion and solidarity among employees, came to symbolise and engender a split between the staff and the other parts of the company. By examining the rise and fall of the value-based management approach, this volume offers the indispensible insight of anthropological enquiry to expose how social realities challenge conventional management strategies and therefore must be considered in the development of new management techniques.

As innovation moves from the lab to the market, a new research phase begins for the entrepreneur: the market research phase. Inspired by a new technology that can change the world, critical questions need to be addressed. Is there a market for my innovation? Who are my clients? What do they need? Is my innovation filling that gap in the market? Who are my competitors? How are they approaching the market? If these questions are unaswered, entrepreneurs meet potential investors or partners with only a basic understanding of their market. The objective of this book is to fill this gap. It is a practical manual that gives entrepreneurs real-world advice and tools to build a solid market model. The book provides tips, models and tools entrepreneurs can use to collect, interpret and present their market and integrate it into their business plan. What the entrepreneur learns in this book will help him throughout his journey. After going over the market research process, he will learn how to design and use a number of market research tools, and how to adapt them in a life science context. From building a web survey to preparing interviews to doing your own secondary research, this handbook will help him gain a comprehensive understanding of how to perform his own market research activities and how to analyze his data. Finally, a number of frameworks (such as the TAM-SAM-SOM as well as the KANO Model) are described so that he can efficiently share what he has learned, using models that simply yet effectively shares findings.